We are live on ! Find out more
GV3

Group VI 31 Portfolio holdings

AUM $1.55M
This Fund
S&P 500
This Quarter Est. Return
+6.4%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.83M
AUM Growth
–
Cap. Flow
+$1.78M
Cap. Flow %
97.31%
Top 10 Hldgs %
100%
Holding
1
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
AH
Accretive Health
AH
+$1.78M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Industrials 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AH
1
DELISTED
Accretive Health
AH
$1.83M 100%
+169,522
New +$1.78M

Similar funds

AIB
Allied Irish Banks Dublin 4, Ireland $1.13M AUM
EA
Endowment Advisers Austin, Texas $49K AUM
EDH
Eric D. Hovde $3.56M AUM
SCM
Straus Capital Management New York $4.65M AUM
TCA
Troob Capital Advisors Rye Brook, New York $5.04M AUM
AIS
APG Investment Services Dj Heerlen, Netherlands $6.7M AUM
LMIE
Legg Mason International Equities London, United Kingdom $8.29M AUM
JCF
J. Christopher Flowers $10.7M AUM

Group VI 31's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Group VI 31, which disclosed 1 position worth $1.83M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Accretive Health: 169,522 shares worth $1.83M.

By sector, the portfolio is most concentrated in Industrials at 100% of assets.

  • Group VI 31's largest Q2 2013 buy was Accretive Health: 169,522 shares worth $1.83M.
  • Group VI 31's ten largest holdings make up 100% of its $1.83M portfolio in Q2 2013.
  • Group VI 31 disclosed 1 position in Q2 2013, its first 13F filing on record.

Based on Group VI 31's 13F filing for Q2 2013, filed 13 Aug 2013.